| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 108,316 | 53,618 | 172,971 | 329,328 | | Cost of Revenue | 64,562 | 42,103 | 103,395 | 191,036 | | | Gross Profit | 43,754 | 11,515 | 69,576 | 138,292 | | | Operating Expenses | | Research Development | 4,556 | (16,518) | 16,518 | (5,670) | | Selling General and Administrative | 42,010 | 23,179 | 54,602 | 111,345 | | Non Recurring |
-
| (11,058) | 76,460 | 20,036 | | Others | 4,946 | 3,381 | 6,144 | 5,797 | | | | Total Operating Expenses |
-
| (1,016) | 153,724 | 131,508 | | | | Operating Income or Loss | (7,758) | 12,531 | (84,148) | 6,784 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16 | (3,339) | 114 | 94 | | Earnings Before Interest And Taxes | (7,742) | 9,192 | (84,034) | 6,878 | | Interest Expense | 1,546 | 1,500 | 1,103 | 2,507 | | Income Before Tax | (9,288) | 7,692 | (85,137) | 4,371 | | Income Tax Expense | (3,622) | (1,997) | (19,362) | 9,482 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,666) | 9,689 | (65,775) | (5,111) | | | Non-recurring Events | | Discontinued Operations | (1,609) | (31,916) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,275) | (22,227) | (65,775) | (5,111) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,275) | ($22,227) | ($65,775) | ($5,111) |
|
0.01% Nasdaq 
0.22%
Income Statement
